Close Menu

When it comes to submitting grants, what does it really mean when a reviewer says you're being "too ambitious" or not ambitious enough? Gerty-Z at Balanced Instability: Adventures on the Tenure Track is confused on this point. When she was writing her first postdoc fellowship application, her advisor warned her not to be "overly ambitious," she says, so she tried to be as conservative as possible. When the review came back telling her she was, indeed, "too ambitious," she thought she wasn't going to get funded.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.